Cowen Prime Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$6K Buy
+400
New +$2.78K ﹤0.01% 186

Other funds holding ASPN

Cowen Prime Advisors's ASPN Position: Q2 2023 in Review

Cowen Prime Advisors increased its Aspen Aerogels (ASPN) stake by 15% in Q2 2023, buying an estimated $1.7M and bringing the position to 1,911,500 shares worth $15.1M. The position accounts for 5.19% of the portfolio, ranked #4.

Cowen Prime Advisors first reported a position in ASPN in Q2 2017 and has held it in 25 quarters since. The position peaked at $17.3M in Q3 2021. 159 funds tracked by Wall St. Rank hold ASPN as of Q2 2023.

  • Cowen Prime Advisors held 1,911,500 shares of Aspen Aerogels worth $15.1M as of Q2 2023.
  • Cowen Prime Advisors bought 244,700 Aspen Aerogels shares in Q2 2023, an estimated $1.7M.
  • Aspen Aerogels made up 5.19% of Cowen Prime Advisors's portfolio in Q2 2023, its #4 holding.
  • Cowen Prime Advisors first reported a position in Aspen Aerogels in Q2 2017 and has held it in 25 quarters since.
  • Cowen Prime Advisors's Aspen Aerogels position peaked at $17.3M in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.